OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
November 15, 2016
Advances in cloud-based IT and user interfaces make it easier to collaborate, but a strong foundation, based on knowledge of data and risk management principles, is needed first.
The half-cycle method for validating sterilization can have adverse effects on materials if used for steam sterilization.
Are investigations supporting or hindering performance excellence?
PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology.
In InstantGMP, cloud-based IT and an approach grounded in cGMPs, brings more of the power of paperless recordkeeping to manufacturers, at a fraction of the cost.
Could greater market transparency improve pharmaceutical quality and regulatory compliance?
Ensuring that materials have optimal critical quality attributes for the required formulations is crucial.
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.